Wojciech Zareba
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Address | Heart Research Follow-up Program
265 Crittenden Blvd.
Rochester NY 14642
|
|---|
|
|
|
| Title | Director, Heart Research |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Division | Medicine - Cardiology |
|---|
|
|---|
|
| 1983 |
|
| Teachers Award of President of Medical University of Lodz | | 1985 |
|
| Scientific Award of President of Medical University of Lodz | | 1987 |
|
| Scientific Award of President of Medical University of Lodz | | 1988 |
|
| Award for the PhD Thesis with Distinction on "Late Potentials in Coronary Artery Disease Patients" | | 1993 |
|
| Best Poster Award XXth International Congress on Electrocardiology | | 1996 |
|
| Fellow of the American College of Cardiology | | 1996 |
|
| Member of the Board of the International Society for Holter and Noninvasive Electrocardiology | | 1996 |
|
| Deputy Editor of the Annals of Noninvasive Electrocardiology | | 1998 |
|
| Del Mar Young Investigator Award for Pioneering Contributions to Medical Science Employing Holter Monitoring Technology | | 2000 |
-
| 2002 | Vice-President of the International Society for Holter and Noninvasive Electrocardiology | | 2001 |
|
| Member of the Board of the International Society of Electrocardiology | | 2002 |
-
| 2005 | President Elect of the International Society for Holter and Noninvasive Electrocardiology | | 2005 |
-
| 2007 | President of the International Society for Holter and Noninvasive Electrocardiology | | 2006 |
|
| Fellow of European Society of Cardiology | | 2006 |
|
| Gold Medal of Polish Cardiac Society | | 2006 |
|
| Editor-In-Chief, Cardiology Journal |
Wojciech Zareba, MD, PhD, is a Professor of Medicine (Cardiology), Director of Cardiology Clinical Research, and Director of the Heart Research Follow Up Program at University of Rochester Medical Center, Rochester, NY. Dr. Zareba is Principal Investigator or Co-PI on several NIH and corporate grants focused on risk stratification of cardiac death and on clinical usefulness and prognostic significance of ECG parameters. He also serves as Principal Investigator of the ECG Core Labs for numerous studies including the International LQTS Registry, the North American ARVD Registry, MADIT II, and MADIT-CRT, large clinical trials testing clinical effectiveness and safety of implantable cardiac defibrillators and resynchronization devices. He participated in a number of corporate research projects focused on evaluating drug safety and participated in a number of advisory councils on the topic of cardiac safety in drug trials. Dr Zareba has authored or co-authored more that 350 publications in cardiology research with many of them focused on sudden death, risk stratification, QT prolongation, and ECG related cardiac safety biomarkers. Dr. Zareba is Past President of the International Society for Holter and Noninvasive Electrocardiology. Dr. Zareba is the Editor in Chief of Cardiology Journal, and Deputy Editor of the Annals of Noninvasive Electrocardiology as well as a member of the editorial boards of a number of other leading cardiology-related journals.
-
Tereshchenko LG, McNitt S, Han L, Berger RD, Zareba W. ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study. PLoS One. 2012; 7(12):e51812.
-
Corino VD, Cygankiewicz I, Mainardi LT, Stridh M, Vasquez R, Bayes de Luna A, Holmqvist F, Zareba W, Platonov PG. Association between Atrial Fibrillatory Rate and Heart Rate Variability in Patients with Atrial Fibrillation and Congestive Heart Failure. Ann Noninvasive Electrocardiol. 2013 Jan; 18(1):41-50.
-
Hoefen R, Reumann M, Goldenberg I, Moss AJ, O-Uchi J, Gu Y, McNitt S, Zareba W, Jons C, Kanters JK, Platonov PG, Shimizu W, Wilde AA, Rice JJ, Lopes CM. In Silico Cardiac Risk Assessment in Patients With Long QT Syndrome: Type 1: Clinical Predictability of Cardiac Models. J Am Coll Cardiol. 2012 Nov 20; 60(21):2182-91.
-
Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 Dec 13; 367(24):2275-83.
-
Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol. 2012 Nov 13; 60(20):1993-2004.
-
Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B, Wang PJ, Moss AJ, Klein H. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2013 Jan; 34(3):184-90.
-
Ouellet G, Huang DT, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Klein H, Zareba W, Goldenberg I. Effect of Cardiac Resynchronization Therapy on the Risk of First and Recurrent Ventricular Tachyarrhythmic Events in MADIT-CRT. J Am Coll Cardiol. 2012 Oct 30; 60(18):1809-16.
-
Bayés de Luna A, Brugada J, Baranchuk A, Borggrefe M, Breithardt G, Goldwasser D, Lambiase P, Riera AP, Garcia-Niebla J, Pastore C, Oreto G, McKenna W, Zareba W, Brugada R, Brugada P. Current electrocardiographic criteria for diagnosis of Brugada pattern: a consensus report. J Electrocardiol. 2012 Sep; 45(5):433-42.
-
Baranchuk A, Nguyen T, Ryu MH, Femenía F, Zareba W, Wilde AA, Shimizu W, Brugada P, Pérez-Riera AR. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol. 2012 Oct; 17(4):299-314.
-
Halamek J, Couderc JP, Jurak P, Vondra V, Zareba W, Viscor I, Leinveber M Sc P. Measure of the QT-RR Dynamic Coupling in Patients with the Long QT Syndrome. Ann Noninvasive Electrocardiol. 2012 Oct; 17(4):323-30.
-
Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S, Moss AJ, Zareba W. QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II. J Cardiovasc Electrophysiol. 2012 Dec; 23(12):1343-8.
-
Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ. Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol. 2012 Jul; 17(3):176-85.
-
Tereshchenko LG, Cygankiewicz I, McNitt S, Vazquez R, Bayes-Genis A, Han L, Sur S, Couderc JP, Berger RD, de Luna AB, Zareba W. Predictive Value of Beat-to-Beat QT Variability Index Across the Continuum of Left Ventricular Dysfunction: Competing Risks of Noncardiac or Cardiovascular Death and Sudden or Nonsudden Cardiac Death. Circ Arrhythm Electrophysiol. 2012 Aug 1; 5(4):719-27.
-
Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol. 2012 Jun 5; 59(23):2075-9.
-
Rich DQ, Zareba W, Beckett W, Hopke PK, Oakes D, Frampton MW, Bisognano J, Chalupa D, Bausch J, O'Shea K, Wang Y, Utell MJ. Are ambient ultrafine, accumulation mode, and fine particles associated with adverse cardiac responses in patients undergoing cardiac rehabilitation? Environ Health Perspect. 2012 Aug; 120(8):1162-9.
-
Couderc JP, Xia X, Denjoy I, Extramiana F, Maison-Blanche P, Moss AJ, Zareba W, Lopes CM. Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome. J Am Heart Assoc. 2012 Apr; 1(2):e000570.
-
Brenyo A, Goldenberg I, Moss AJ, Rao M, McNitt S, Huang DT, Zareba W, Barsheshet A. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT. Heart Rhythm. 2012 Sep; 9(9):1454-9.
-
Zareba W. Letter from the New Editor-in-Chief. Ann Noninvasive Electrocardiol. 2012 Apr; 17(2):69.
-
Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM. Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to ß-Blocker Therapy in Type 1 Long-QT Syndrome. Circulation. 2012 Apr 24; 125(16):1988-96.
-
Costa J, Lopes CM, Barsheshet A, Moss AJ, Migdalovich D, Ouellet G, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm. 2012 Jun; 9(6):892-8.
-
Platonov PG, Cygankiewicz I, Stridh M, Holmqvist F, Vazquez R, Bayes-Genis A, McNitt S, Zareba W, de Luna AB. Low atrial fibrillatory rate is associated with poor outcome in patients with mild to moderate heart failure. Circ Arrhythm Electrophysiol. 2012 Feb 1; 5(1):77-83.
-
Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes DL, Kirchhof P, Breithardt G, Zareba W, Schuger C, Aktas MK, Chudzik M, Mittal S, Varma N. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace. 2012 Feb; 14(2):278-93.
-
Dubner S, Auricchio A, Steinberg JS, Vardas P, Stone P, Brugada J, Piotrowicz R, Hayes DL, Kirchhof P, Breithardt G, Zareba W, Schuger C, Aktas MK, Chudzik M, Mittal S, Varma N. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol. 2012 Jan; 17(1):36-56.
-
Pietrasik G, Zareba W. QRS fragmentation: Diagnostic and prognostic significance. Cardiol J. 2012; 19(2):114-21.
-
Zareba W. Cardiology journal: first impact factor = 1.309. Cardiol J. 2012; 19(4):1-2.
-
Hampel R, Breitner S, Zareba W, Kraus U, Pitz M, Geruschkat U, Belcredi P, Peters A, Schneider A. Immediate ozone effects on heart rate and repolarisation parameters in potentially susceptible individuals. Occup Environ Med. 2012 Jun; 69(6):428-36.
-
Hampel R, Breitner S, Schneider A, Zareba W, Kraus U, Cyrys J, Geruschkat U, Belcredi P, Müller M, Wichmann HE, Peters A. Acute air pollution effects on heart rate variability are modified by SNPs involved in cardiac rhythm in individuals with diabetes or impaired glucose tolerance. Environ Res. 2012 Jan; 112:177-85.
-
Corsetti JP, Ryan D, Moss AJ, McCarthy J, Goldenberg I, Zareba W, Sparks CE. Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Thromb Haemost. 2011 Nov 30; 106(6):1170-8.
-
Brenyo A, Link MS, Barsheshet A, Moss AJ, Zareba W, Wang PJ, McNitt S, Huang D, Foster E, Estes M, Solomon SD, Goldenberg I. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Oct 11; 58(16):1682-9.
-
Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, Solomon S, Steinberg JS, Wilber D, Barsheshet A, McNitt S, Zareba W, Klein H. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Oct 4; 124(14):1527-36.
-
Rao M, Goldenberg I, Moss AJ, Klein H, Huang DT, Bianco NR, Szymkiewicz SJ, Zareba W, Brenyo A, Buber J, Barsheshet A. Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol. 2011 Dec 1; 108(11):1632-8.
-
Goldenberg I, Thottathil P, Lopes CM, Moss AJ, McNitt S, O-Uchi J, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Barsheshet A. Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome. Heart Rhythm. 2012 Jan; 9(1):49-56.
-
Hoffmayer KS, Machado ON, Marcus GM, Yang Y, Johnson CJ, Ermakov S, Vittinghoff E, Pandurangi U, Calkins H, Cannom D, Gear KC, Tichnell C, Park Y, Zareba W, Marcus FI, Scheinman MM. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2011 Aug 16; 58(8):831-8.
-
Barsheshet A, Moss AJ, McNitt S, Polonsky S, Lopes CM, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Towbin JA, Vincent GM, Qi M, Goldenberg I. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation. Circ Cardiovasc Genet. 2011 Oct; 4(5):491-9.
-
Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Aug 9; 58(7):729-37.
-
Penn J, Goldenberg I, Moss AJ, McNitt S, Zareba W, Klein HU, Cannom DS, Solomon SD, Barsheshet A, Huang DT. Improved outcome with preventive cardiac resynchronization therapy in the elderly: a MADIT-CRT substudy. J Cardiovasc Electrophysiol. 2011 Aug; 22(8):892-7.
-
Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S, Foster E, Huang DT, Klein HU, Zareba W, Eldar M, Goldenberg I. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Jun 14; 57(24):2416-23.
-
Buber J, Klein H, Moss AJ, McNitt S, Eldar M, Padeletti L, Vogt J, Meine M, Brown MW, Barsheshet A, Zareba W, Goldenberg I. Clinical course and outcome of patients enrolled in US and non-US centres in MADIT-CRT. Eur Heart J. 2011 Nov; 32(21):2697-704.
-
Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP, Lloyd-Jones D, Kadish AH, Lee B, Moss A, Myerburg R, Olgin J, Passman R, Rosenbaum D, Stevenson W, Zareba W, Zipes DP. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011 May 31; 123(21):2423-30.
-
Buber J, Mathew J, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Luria D, Eldar M, Towbin JA, Vincent M, Goldenberg I. Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. Circulation. 2011 Jun 21; 123(24):2784-91.
-
Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial. J Cardiovasc Electrophysiol. 2011 Nov; 22(11):1237-42.
-
Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011 Jul; 32(14):1720-9.
-
Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, Foster E, Zareba W, Goldenberg I, McNitt S, Pfeffer MA, Moss AJ, Solomon SD. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail. 2011 Jul; 4(4):433-40.
-
Jons C, O-Uchi J, Moss AJ, Reumann M, Rice JJ, Goldenberg I, Zareba W, Wilde AA, Shimizu W, Kanters JK, McNitt S, Hofman N, Robinson JL, Lopes CM. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients. Sci Transl Med. 2011 Mar 30; 3(76):76ra28.
-
Migdalovich D, Moss AJ, Lopes CM, Costa J, Ouellet G, Barsheshet A, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011 Oct; 8(10):1537-43.
-
Barsheshet A, Peterson DR, Moss AJ, Schwartz PJ, Kaufman ES, McNitt S, Polonsky S, Buber J, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Towbin JA, Vincent GM, Zhang L, Goldenberg I. Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. Heart Rhythm. 2011 Aug; 8(8):1207-13.
-
Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, Barsheshet A, Cannom D, Goldenberg I, McNitt S, Daubert JP, Zareba W, Moss AJ. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2011 Mar 22; 123(11):1159-66.
-
Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Mar 15; 123(10):1061-72.
-
Liu JF, Jons C, Moss AJ, McNitt S, Peterson DR, Qi M, Zareba W, Robinson JL, Barsheshet A, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin J, Vincent M, Zhang L, Goldenberg I. Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT Syndrome. J Am Coll Cardiol. 2011 Feb 22; 57(8):941-50.
-
Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, Greenberg H, Hall WJ, McNitt S, Zareba W, Solomon S, Steinberg JS. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol. 2011 Feb 15; 57(7):813-20.
-
Couderc JP, Xia X, Peterson DR, McNitt S, Zhao H, Polonsky S, Moss AJ, Zareba W. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. Heart Rhythm. 2011 Jul; 8(7):1036-43.
-
Horr S, Goldenberg I, Moss AJ, O-Uchi J, Barsheshet A, Connelly H, Gray DA, Zareba W, Lopes CM. Ion channel mechanisms related to sudden cardiac death in phenotype-negative long-QT syndrome genotype-phenotype correlations of the KCNQ1(S349W) mutation. J Cardiovasc Electrophysiol. 2011 Feb; 22(2):193-200.
-
Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2011 Jan 4; 57(1):51-9.
-
Couderc JP, Garnett C, Li M, Handzel R, McNitt S, Xia X, Polonsky S, Zareba W. Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines. Ann Noninvasive Electrocardiol. 2011 Jan; 16(1):13-24.
-
Zareba W. Cardiology Journal - five years later. Cardiol J. 2011; 18(1):1-2.
-
Williams ES, Hall B, Traub D, Bahnson T, Hranitzky P, Zareba W, Daubert JP. Catheter ablation of atrial fibrillation in the elderly. Curr Opin Cardiol. 2011 Jan; 26(1):25-9.
-
Sherazi S, Zareba W. Diastolic heart failure: predictors of mortality. Cardiol J. 2011; 18(3):222-32.
-
Zareba W. Counting mRNA in blood of LQTS - new direction? Kardiol Pol. 2011; 69(5):430.
-
Brenyo A, Zareba W. Prognostic significance of QRS duration and morphology. Cardiol J. 2011; 18(1):8-17.
-
Lane RD, Zareba W, Reis HT, Peterson DR, Moss AJ. Changes in ventricular repolarization duration during typical daily emotion in patients with Long QT syndrome. Psychosom Med. 2011 Jan; 73(1):98-105.
-
Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, McNitt S, Klein HU, Hall WJ, Brown MW, Goldberger JJ, Goldstein RE, Schuger C, Zareba W, Daubert JP. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J. 2011 Jul; 32(13):1622-30.
-
Barsheshet A, Moss AJ, Eldar M, Huang DT, Hall WJ, Klein HU, McNitt S, Steinberg JS, Wilber DJ, Zareba W, Goldenberg I. Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction. Eur Heart J. 2011 Jul; 32(13):1614-21.
-
Sze E, Moss AJ, McNitt S, Barsheshet A, Andrews ML, Zareba W, Goldenberg I. Risk factors for recurrent heart failure events in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Cardiovasc Electrophysiol. 2010 Nov; 21(11):1217-23.
-
Zhang T, Moss A, Cong P, Pan M, Chang B, Zheng L, Fang Q, Zareba W, Robinson J, Lin C, Li Z, Wei J, Zeng Q. LQTS gene LOVD database. Hum Mutat. 2010 Nov; 31(11):E1801-10.
-
Barsheshet A, Moss AJ, McNitt S, Jons C, Glikson M, Klein HU, Huang DT, Steinberg JS, Brown MW, Zareba W, Goldenberg I. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2011 Feb; 8(2):212-8.
-
Dabrowski R, Borowiec A, Smolis-Bak E, Kowalik I, Sosnowski C, Kraska A, Kazimierska B, Wozniak J, Zareba W, Szwed H. Effect of combined spironolactone-ß-blocker ± enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). Am J Cardiol. 2010 Dec 1; 106(11):1609-14.
-
Kamath GS, Zareba W, Delaney J, Koneru JN, McKenna W, Gear K, Polonsky S, Sherrill D, Bluemke D, Marcus F, Steinberg JS. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011 Feb; 8(2):256-62.
-
Schneider A, Hampel R, Ibald-Mulli A, Zareba W, Schmidt G, Schneider R, Rückerl R, Couderc JP, Mykins B, Oberdörster G, Wölke G, Pitz M, Wichmann HE, Peters A. Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease. Part Fibre Toxicol. 2010; 7:29.
-
Burattini L, Zareba W, Burattini R. Identification of gender-related normality regions for T-wave alternans. Ann Noninvasive Electrocardiol. 2010 Oct; 15(4):328-36.
-
Kim JA, Lopes CM, Moss AJ, McNitt S, Barsheshet A, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Goldenberg I. Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm. 2010 Dec; 7(12):1797-805.
-
Goldenberg I, Moss AJ, McNitt S, Barsheshet A, Gray D, Andrews ML, Brown MW, Zareba W, Sze E, Solomon SD, Pfeffer MA. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm. 2010 Dec; 7(12):1777-82.
-
Hampel R, Schneider A, Brüske I, Zareba W, Cyrys J, Rückerl R, Breitner S, Korb H, Sunyer J, Wichmann HE, Peters A. Altered cardiac repolarization in association with air pollution and air temperature among myocardial infarction survivors. Environ Health Perspect. 2010 Dec; 118(12):1755-61.
-
Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation. 2010 Sep 28; 122(13):1265-71.
-
Barsheshet A, Goldenberg I, Narins CR, Moss AJ, McNitt S, Wang PJ, Huang DT, Hall WJ, Zareba W, Eldar M, Guetta V. Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT. Heart Rhythm. 2010 Oct; 7(10):1421-7.
-
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Sparks CE. Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels. Arterioscler Thromb Vasc Biol. 2010 Aug; 30(8):1657-64.
-
Zareba W. Challenges of diagnosing long QT syndrome in patients with nondiagnostic resting QTc. J Am Coll Cardiol. 2010 May 4; 55(18):1962-4.
-
Morin DP, Mauer AC, Gear K, Zareba W, Markowitz SM, Marcus FI, Lerman BB. Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right ventricular outflow tract. Am J Cardiol. 2010 Jun 15; 105(12):1821-4.
-
Goldenberg I, Bradley J, Moss A, McNitt S, Polonsky S, Robinson JL, Andrews M, Zareba W. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol. 2010 Aug 1; 21(8):893-901.
-
Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010 Mar 2; 55(9):934-47.
-
Zareba W, Zareba KM. Which patients with chronic heart failure should be referred for CRT-D implantation? Practical implications of current clinical research. Pol Arch Med Wewn. 2010 Mar; 120(3):95-102.
-
Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W, Qi M, Robinson JL. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol. 2010 Feb 23; 55(8):783-8.
-
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010 Apr; 31(7):806-14.
-
Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010 Apr 6; 121(13):1533-41.
-
Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Pillichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010 Feb 9; 55(6):587-97.
-
Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2010 Mar 2; 121(8):1047-60.
-
Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Am J Cardiol. 2010 Mar 1; 105(5):581-6.
-
Liu JF, Moss AJ, Jons C, Benhorin J, Schwartz PJ, Spazzolini C, Crotti L, Ackerman MJ, McNitt S, Robinson JL, Qi M, Goldenberg I, Zareba W. Mutation-specific risk in two genetic forms of type 3 long QT syndrome. Am J Cardiol. 2010 Jan 15; 105(2):210-3.
-
Amino M, Yoshioka K, Fujibayashi D, Hashida T, Furusawa Y, Zareba W, Ikari Y, Tanaka E, Mori H, Inokuchi S, Kodama I, Tanabe T. Year-long upregulation of connexin43 in rabbit hearts by heavy ion irradiation. Am J Physiol Heart Circ Physiol. 2010 Mar; 298(3):H1014-21.
-
Sherazi S, Zareba W, Daubert JP, McNitt S, Shah AH, Aktas MK, Block RC. Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators. Cardiol J. 2010; 17(3):267-73.
-
Zareba W. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure. Cardiol J. 2010; 17(6):543-8.
-
Holmqvist F, Platonov PG, McNitt S, Polonsky S, Carlson J, Zareba W, Moss AJ. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):63-72.
-
Fugate T, Moss AJ, Jons C, McNitt S, Mullally J, Ouellet G, Goldenberg I, Zareba W, Robinson JL. Long QT syndrome in African-Americans. Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):73-6.
-
Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010 Jan 1; 105(1):95-9.
-
Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol. 2009 Nov 24; 54(22):2052-62.
-
Nikus K, Pahlm O, Wagner G, Birnbaum Y, Cinca J, Clemmensen P, Eskola M, Fiol M, Goldwasser D, Gorgels A, Sclarovsky S, Stern S, Wellens H, Zareba W, de Luna AB. Electrocardiographic classification of acute coronary syndromes: a review by a committee of the International Society for Holter and Non-Invasive Electrocardiology. J Electrocardiol. 2010 Mar-Apr; 43(2):91-103.
-
Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010 Mar; 33(3):353-67.
-
Zareba W. It is time to check estimated glomerular filtration rate level in implantable cardioverter-defibrillator patients. Europace. 2009 Nov; 11(11):1415-6.
-
Ouellet G, Moss AJ, Jons C, McNitt S, Mullally J, Fugate T, Goldenberg I, Zareba W, Robinson JL. Influence of diabetes mellitus on outcome in patients over 40 years of age with the long QT syndrome. Am J Cardiol. 2010 Jan 1; 105(1):87-9.
-
Burattini L, Zareba W, Burattini R. Assessment of physiological amplitude, duration, and magnitude of ECG T-wave alternans. Ann Noninvasive Electrocardiol. 2009 Oct; 14(4):366-74.
-
Aktas MK, Kim DD, McNitt S, Huang DT, Rosero SZ, Hall BW, Zareba W, Daubert JP. Right ventricular dysfunction and the incidence of implantable cardioverter-defibrillator therapies. Pacing Clin Electrophysiol. 2009 Dec; 32(12):1501-8.
-
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009 Oct 1; 361(14):1329-38.
-
Spazzolini C, Mullally J, Moss AJ, Schwartz PJ, McNitt S, Ouellet G, Fugate T, Goldenberg I, Jons C, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Crotti L, Kaufman ES, Locati EH, Qi M, Napolitano C, Priori SG, Towbin JA, Vincent GM. Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. J Am Coll Cardiol. 2009 Aug 25; 54(9):832-7.
-
Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes NA, Marcus F, Scheinman MM. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009 Aug 11; 54(7):609-15.
-
Holmqvist F, Platonov PG, Carlson J, Zareba W, Moss AJ. Altered interatrial conduction detected in MADIT II patients bound to develop atrial fibrillation. Ann Noninvasive Electrocardiol. 2009 Jul; 14(3):268-75.
-
Block R, Corsetti J, Goldenberg I, Vorobiof G, McNitt S, Ryan D, Zareba W, Moss AJ. The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction. Heart Int. 2009 Jun 30; 4(1):e8.
-
Cygankiewicz I, Zareba W, Vazquez R, Bayes-Genis A, Pascual D, Macaya C, Almendral J, Fiol M, Bardaji A, Gonzalez-Juanatey JR, Nieto V, Valdes M, Cinca J, de Luna AB. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. Am J Cardiol. 2009 Apr 1; 103(7):1003-10.
-
Lane RD, Reis HT, Peterson DR, Zareba W, Moss AJ. Happiness and stress alter susceptibility to cardiac events in Long QT Syndrome. Ann Noninvasive Electrocardiol. 2009 Apr; 14(2):193-200.
-
Jons C, Moss AJ, Lopes CM, McNitt S, Zareba W, Goldenberg I, Qi M, Wilde AA, Shimizu W, Kanters JK, Towbin JA, Ackerman MJ, Robinson JL. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):859-65.
-
Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, Bluemke DA, Estes NA, Picard MH, Sanborn D, Thiene G, Wichter T, Cannom D, Wilber DJ, Scheinman M, Duff H, Daubert J, Talajic M, Krahn A, Sweeney M, Garan H, Sakaguchi S, Lerman BB, Kerr C, Kron J, Steinberg JS, Sherrill D, Gear K, Brown M, Severski P, Polonsky S, McNitt S. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009 Jul; 6(7):984-92.
-
Marcus FI, Zareba W. The electrocardiogram in right ventricular cardiomyopathy/dysplasia. How can the electrocardiogram assist in understanding the pathologic and functional changes of the heart in this disease? J Electrocardiol. 2009 Mar-Apr; 42(2):136.e1-5.
-
Zareba W, Couderc JP, Oberdörster G, Chalupa D, Cox C, Huang LS, Peters A, Utell MJ, Frampton MW. ECG parameters and exposure to carbon ultrafine particles in young healthy subjects. Inhal Toxicol. 2009 Feb; 21(3):223-33.
-
Zareba W. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions. Cardiol J. 2009; 16(5):391-3.
-
Traub D, Daubert JP, McNitt S, Zareba W, Hall B. Catheter ablation of atrial fibrillation in the elderly: where do we stand? Cardiol J. 2009; 16(2):113-20.
-
Jeevanantham V, Daubert JP, Zareba W. Cardiac resynchronization therapy in heart failure patients: an update. Cardiol J. 2009; 16(3):197-209.
-
Couderc JP, Zareba W. An update on QT measurement and interpretation methodologies. Ann Noninvasive Electrocardiol. 2009 Jan; 14 Suppl 1:S1-2.
-
Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H, McNitt S, Polonsky S, Andrews M, Dwyer EM, Hall WJ, Moss AJ. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm. 2009 Apr; 6(4):468-73.
-
Haigney MC, Zareba W, Nasir JM, McNitt S, McAdams D, Gentlesk PJ, Goldstein RE, Moss AJ. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm. 2009 Feb; 6(2):180-6.
-
Zareba W, Cygankiewicz I. Long QT syndrome and short QT syndrome. Prog Cardiovasc Dis. 2008 Nov-Dec; 51(3):264-78.
-
Goldenberg I, Zareba W, Moss AJ. Long QT Syndrome. Curr Probl Cardiol. 2008 Nov; 33(11):629-94.
-
Narins CR, Zareba W, Rocco V, McNitt S. A prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention. J Invasive Cardiol. 2008 Nov; 20(11):579-84.
-
Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes. J Clin Pharmacol. 2009 Jan; 49(1):6-16.
-
Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. J Cardiovasc Electrophysiol. 2009 Apr; 20(4):395-400.
-
Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus. J Am Coll Cardiol. 2008 Oct 21; 52(17):1353-65.
-
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE. Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. Obesity (Silver Spring). 2008 Dec; 16(12):2717-22.
-
Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL. Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease. Ann Noninvasive Electrocardiol. 2008 Oct; 13(4):327-31.
-
Couderc JP, Zhou M, Sarapa N, Zareba W. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals. J Electrocardiol. 2008 Nov-Dec; 41(6):595-602.
-
Levine E, Rosero SZ, Budzikowski AS, Moss AJ, Zareba W, Daubert JP. Congenital long QT syndrome: considerations for primary care physicians. Cleve Clin J Med. 2008 Aug; 75(8):591-600.
-
Al-Khatib SM, Sanders GD, Carlson M, Cicic A, Curtis A, Fonarow GC, Groeneveld PW, Hayes D, Heidenreich P, Mark D, Peterson E, Prystowsky EN, Sager P, Salive ME, Thomas K, Yancy CW, Zareba W, Zipes D. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J. 2008 Oct; 156(4):613-22.
-
Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008 Dec; 19(12):1289-93.
-
Thottathil P, Acharya J, Moss AJ, Jons C, McNitt S, Goldenberg I, Zareba W, Kaufman E, Qi M, Robinson JL. Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists. Am J Cardiol. 2008 Oct 1; 102(7):871-4.
-
Burattini L, Zareba W, Burattini R. Adaptive match filter based method for time vs. amplitude characterization of microvolt ECG T-wave alternans. Ann Biomed Eng. 2008 Sep; 36(9):1558-64.
-
Goldenberg I, Moss AJ, Ryan D, Pietrasik G, Zareba W, McNitt S, Eberly SW. Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach. Ann Noninvasive Electrocardiol. 2008 Jul; 13(3):287-94.
-
Liu JF, Goldenberg I, Moss AJ, Shimizu W, Wilde AA, Hofman N, McNitt S, Zareba W, Miyamato Y, Robinson JL, Andrews ML. Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations. Ann Noninvasive Electrocardiol. 2008 Jul; 13(3):234-41.
-
Cygankiewicz I, Zareba W, Vazquez R, Almendral J, Bayes-Genis A, Fiol M, Valdes M, Macaya C, Gonzalez-Juanatey JR, Cinca J, Bayes de Luna A. Prognostic value of QT/RR slope in predicting mortality in patients with congestive heart failure. J Cardiovasc Electrophysiol. 2008 Oct; 19(10):1066-72.
-
Cygankiewicz I, Zareba W, Vazquez R, Vallverdu M, Gonzalez-Juanatey JR, Valdes M, Almendral J, Cinca J, Caminal P, de Luna AB. Heart rate turbulence predicts all-cause mortality and sudden death in congestive heart failure patients. Heart Rhythm. 2008 Aug; 5(8):1095-1102.
-
Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008 Apr 29; 117(17):2184-91.
-
Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long-QT syndrome after age 40. Circulation. 2008 Apr 29; 117(17):2192-201.
-
Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 Apr 8; 51(14):1357-65.
-
Kaufman ES, McNitt S, Moss AJ, Zareba W, Robinson JL, Hall WJ, Ackerman MJ, Benhorin J, Locati ET, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm. 2008 Jun; 5(6):831-6.
-
Dhar R, Alsheikh-Ali AA, Estes NA, Moss AJ, Zareba W, Daubert JP, Greenberg H, Case RB, Kent DM. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm. 2008 Jun; 5(6):807-13.
-
Anthony R, Daubert JP, Zareba W, Andrews ML, McNitt S, Levine E, Huang DT, Hall WJ, Moss AJ. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2008 Feb; 31(2):144-50.
-
Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008 Jan 22; 51(3):288-96.
-
Cygankiewicz I, Zareba W, de Luna AB. Prognostic value of Holter monitoring in congestive heart failure. Cardiol J. 2008; 15(4):313-23.
-
Zareba W. Hyperglycemia as a risk factor in postinfarction patients. Cardiol J. 2008; 15(5):399-401.
-
Mieszczanska H, Pietrasik G, Piotrowicz K, McNitt S, Moss AJ, Zareba W. Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction. Am J Cardiol. 2008 Jan 1; 101(1):20-4.
-
Couderc JP, McNitt S, Hyrien O, Vaglio M, Xia X, Polonsky S, Moss AJ, Zareba W. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. Drug Saf. 2008; 31(3):249-60.
-
Jeevanantham V, Zareba W, Navaneethan S, Fitzgerald D, Yu CM, Achilli A, Bax J, Daubert J. Metaanalysis on effects of cardiac resynchronization therapy in heart failure patients with narrow QRS complex. Cardiol J. 2008; 15(3):230-6.
-
Kamousi B, Lin B, Al-Ahmad A, Hsia H, Zei P, Natale A, Moss A, Daubert J, Zareba W, Wang P. A covariance-based algorithm: a novel technique for rhythm discrimination in ICDs. Conf Proc IEEE Eng Med Biol Soc. 2008; 2008:5478-81.
-
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):548-54.
-
Couderc JP, Vaglio M, Xia X, McNitt S, Wicker P, Sarapa N, Moss AJ, Zareba W. Impaired T-amplitude adaptation to heart rate characterizes I(Kr) inhibition in the congenital and acquired forms of the long QT syndrome. J Cardiovasc Electrophysiol. 2007 Dec; 18(12):1299-305.
-
Fossa AA, Wisialowski T, Crimin K, Wolfgang E, Couderc JP, Hinterseer M, Kaab S, Zareba W, Badilini F, Sarapa N. Analyses of dynamic beat-to-beat QT-TQ interval (ECG restitution) changes in humans under normal sinus rhythm and prior to an event of torsades de pointes during QT prolongation caused by sotalol. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):338-48.
-
Goldenberg I, Moss AJ, Block R, Ryan D, Corsetti JP, McNitt S, Eberly SW, Zareba W. Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):364-74.
-
Vaglio M, Couderc JP, McNitt S, Xia X, Moss AJ, Zareba W. A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology. Heart Rhythm. 2008 Jan; 5(1):11-8.
-
Couderc JP, Zareba W, McNitt S, Maison-Blanche P, Moss AJ. Repolarization variability in the risk stratification of MADIT II patients. Europace. 2007 Sep; 9(9):717-23.
-
Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007 Nov; 4(11):1395-402.
-
Pietrasik G, Goldenberg I, Zdzienicka J, Moss AJ, Zareba W. Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction. Am J Cardiol. 2007 Aug 15; 100(4):583-6.
-
Zareba W. Holter electrocardiogram parameters in risk stratification of arrhythmic events in idiopathic dilated cardiomyopathy: more studies are needed. J Am Coll Cardiol. 2007 Jul 17; 50(3):232-3.
-
Al-Khatib SM, Sanders GD, Bigger JT, Buxton AE, Califf RM, Carlson M, Curtis A, Curtis J, Fain E, Gersh BJ, Gold MR, Haghighi-Mood A, Hammill SC, Healey J, Hlatky M, Hohnloser S, Kim RJ, Lee K, Mark D, Mianulli M, Mitchell B, Prystowsky EN, Smith J, Steinhaus D, Zareba W. Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death. Am Heart J. 2007 Jun; 153(6):941-50.
-
Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007 Aug; 18(8):833-8.
-
Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007 May 15; 115(19):2481-9.
-
Dubner SJ, Moss AJ, Schapachnik ES, Levine PA, Perez Riera AR, Camm J, Zareba W. Web-based virtual cardiac symposia: a new approach for worldwide professional medical education. Ann Noninvasive Electrocardiol. 2007 Apr; 12(2):165-70.
-
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr; 153(4 Suppl):53-8.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2007 Apr 3; 49(13):1427-33.
-
Shenkman HJ, Zareba W, Bisognano JD. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure. Am J Cardiol. 2007 Apr 15; 99(8):1143-5.
-
Yue W, Schneider A, Stölzel M, Rückerl R, Cyrys J, Pan X, Zareba W, Koenig W, Wichmann HE, Peters A. Ambient source-specific particles are associated with prolonged repolarization and increased levels of inflammation in male coronary artery disease patients. Mutat Res. 2007 Aug 1; 621(1-2):50-60.
-
Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007 Mar 13; 49(10):1092-8.
-
Morray B, Goldenberg I, Moss AJ, Zareba W, Ryan D, McNitt S, Eberly SW, Glazko G, Mathew J. Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction. Am J Cardiol. 2007 Apr 15; 99(8):1100-5.
-
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients. Diabetes. 2007 May; 56(5):1429-35.
-
Piotrowicz K, Noyes K, Lyness JM, McNitt S, Andrews ML, Dick A, Hall WJ, Moss AJ, Zareba W. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J. 2007 Mar; 28(5):601-7.
-
Marcus FI, Zareba W, Sherrill D. Evaluation of the normal values for signal-averaged electrocardiogram. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):231-3.
-
Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):181-4.
-
Corsetti JP, Ryan D, Moss AJ, Zareba W, Sparks CE. NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients. Atherosclerosis. 2008 Jan; 196(1):461-8.
-
Gomez JF, Zareba W, Moss AJ, McNitt S, Hall WJ. Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction. Am J Cardiol. 2007 Mar 1; 99(5):642-6.
-
Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, Qi M, Goldenberg I, Hobbs JB, Ackerman MJ, Benhorin J, Hall WJ, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome in adults. J Am Coll Cardiol. 2007 Jan 23; 49(3):329-37.
-
Bayés de Luna A, Zareba W. New terminology of the cardiac walls and new classification of Q-wave M infarction based on cardiac magnetic resonance correlations. Ann Noninvasive Electrocardiol. 2007 Jan; 12(1):1-4.
-
Elder A, Couderc JP, Gelein R, Eberly S, Cox C, Xia X, Zareba W, Hopke P, Watts W, Kittelson D, Frampton M, Utell M, Oberdörster G. Effects of on-road highway aerosol exposures on autonomic responses in aged, spontaneously hypertensive rats. Inhal Toxicol. 2007 Jan; 19(1):1-12.
-
Zareba W. Drug induced QT prolongation. Cardiol J. 2007; 14(6):523-33.
-
Yue W, Schneider A, Rückerl R, Koenig W, Marder V, Wang S, Wichmann HE, Peters A, Zareba W. Relationship between electrocardiographic and biochemical variables in coronary artery disease. Int J Cardiol. 2007 Jul 10; 119(2):185-91.
-
Piotrowicz K, Zareba W, McNitt S, Moss AJ. Repolarization duration in patients with conduction disturbances after myocardial infarction. Am J Cardiol. 2007 Jan 15; 99(2):163-8.
-
Berger A, Zareba W, Schneider A, Rückerl R, Ibald-Mulli A, Cyrys J, Wichmann HE, Peters A. Runs of ventricular and supraventricular tachycardia triggered by air pollution in patients with coronary heart disease. J Occup Environ Med. 2006 Nov; 48(11):1149-58.
-
Cygankiewicz I, Zareba W, Vazquez R, Vallverdu M, Cino J, Cinca J, Almendral J, Gonzalez Juanatey JR, Macaya C, Valdes M, Caminal P, Bayes de Luna A. Relation of heart rate turbulence to severity of heart failure. Am J Cardiol. 2006 Dec 15; 98(12):1635-40.
-
Bayés de Luna A, Wagner G, Birnbaum Y, Nikus K, Fiol M, Gorgels A, Cinca J, Clemmensen PM, Pahlm O, Sclarovsky S, Stern S, Wellens H, Zareba W. A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation. 2006 Oct 17; 114(16):1755-60.
-
Vorobiof G, Goldenberg I, Moss AJ, Zareba W, McNitt S. Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol. 2006 Nov 15; 98(10):1383-6.
-
Amino M, Yoshioka K, Tanabe T, Tanaka E, Mori H, Furusawa Y, Zareba W, Yamazaki M, Nakagawa H, Honjo H, Yasui K, Kamiya K, Kodama I. Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction. Cardiovasc Res. 2006 Dec 1; 72(3):412-21.
-
Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, Qi M, Robinson JL, Sauer AJ, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Towbin JA, Vincent GM, Zhang L. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006 Sep 13; 296(10):1249-54.
-
Zareba W. Genotype-specific ECG patterns in long QT syndrome. J Electrocardiol. 2006 Oct; 39(4 Suppl):S101-6.
-
Goldenberg I, Moss AJ, Ryan D, McNitt S, Eberly SW, Zareba W. Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events. Hypertension. 2006 Oct; 48(4):693-9.
-
Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, Ackerman MJ, Murphy L. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006 Nov; 17(11):1161-8.
-
Couderc JP, McNitt S, Xia J, Zareba W, Moss AJ. Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval. Heart Rhythm. 2006 Dec; 3(12):1460-6.
-
Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol. 2006 Sep 5; 48(5):1047-52.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, Case RB. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol. 2006 Aug 15; 98(4):485-90.
-
Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006 Jun 20; 113(24):2810-7.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ, Andrews ML. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 Sep; 17(9):931-6.
-
Narins CR, Ling FS, Fischi M, Peterson DR, Bausch J, Zareba W. In-hospital mortality among women undergoing contemporary elective percutaneous coronary intervention: a reexamination of the gender gap. Clin Cardiol. 2006 Jun; 29(6):254-8.
-
Corsetti JP, Rainwater DL, Moss AJ, Zareba W, Sparks CE. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients. Clin Chem. 2006 Jul; 52(7):1331-8.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 May 2; 47(9):1811-7.
-
Zareba W. Should QT replace ST for detecting myocardial ischemia? Heart Rhythm. 2006 Apr; 3(4):433-4.
-
Rashba EJ, Estes NA, Wang P, Schaechter A, Howard A, Zareba W, Couderc JP, Perkiomaki J, Levine J, Kadish A. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm. 2006 Mar; 3(3):281-6.
-
Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol. 2006 Mar; 17(3):333-6.
-
Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm. 2006 Jun; 3(6):631-7.
-
Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 Feb 21; 47(4):769-73.
-
Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006 Jan 3; 47(1):98-107.
-
Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005 Dec; 16(12):1265-70.
-
Corsetti JP, Zareba W, Moss AJ, Rainwater DL, Sparks CE. Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. Atherosclerosis. 2006 Jul; 187(1):191-7.
-
Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol. 2005 Nov 1; 46(9):1712-20.
-
Badilini F, Erdem T, Zareba W, Moss AJ. ECGScan: a method for conversion of paper electrocardiographic printouts to digital electrocardiographic files. J Electrocardiol. 2005 Oct; 38(4):310-8.
-
Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4):429-35.
-
Zareba W. Noninvasive electrocardiology in 2005 and beyond: letter from ISHNE President. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4):393-5.
-
Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Higgins SL, Klein H, Pfeffer M, Wilber D, Zareba W. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):34-43.
-
Moss AJ, Windle JR, Hall WJ, Zareba W, Robinson JL, McNitt S, Severski P, Rosero S, Daubert JP, Qi M, Cieciorka M, Manalan AS. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):59-66.
-
Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):67-83.
-
Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, Hall WJ, Andrews M, McNitt S, Daubert JP. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol. 2005 Sep 1; 96(5):691-5.
-
Goldenberg I, Moss AJ, Zareba W. Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes. Curr Cardiol Rep. 2005 Sep; 7(5):349-56.
-
Wittenberg SM, Cook JR, Hall WJ, McNitt S, Zareba W, Moss AJ. Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus. Am J Cardiol. 2005 Aug 1; 96(3):417-9.
-
Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. Am J Cardiol. 2005 Jul 15; 96(2):177-82.
-
Zareba W, Piotrowicz K, McNitt S, Moss AJ. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol. 2005 Jun 15; 95(12):1487-91.
-
Corsetti JP, Zareba W, Moss AJ, Sparks CE. Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients. Atherosclerosis. 2005 Dec; 183(2):293-300.
-
Wranicz JK, Cygankiewicz I, Rosiak M, Kula P, Kula K, Zareba W. The relationship between sex hormones and lipid profile in men with coronary artery disease. Int J Cardiol. 2005 May 11; 101(1):105-10.
-
Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, Andrews M, Brown M, Hall WJ, Zareba W, Moss AJ. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol. 2005 Apr; 16(4):359-65.
-
Henneberger A, Zareba W, Ibald-Mulli A, Rückerl R, Cyrys J, Couderc JP, Mykins B, Woelke G, Wichmann HE, Peters A. Repolarization changes induced by air pollution in ischemic heart disease patients. Environ Health Perspect. 2005 Apr; 113(4):440-6.
-
Alonso JL, Martínez P, Vallverdú M, Cygankiewicz I, Pitzalis MV, Bayés Genís A, Cinca J, Rizzon P, Caminal P, Zareba W, Bayés de Luna A. Dynamics of ventricular repolarization in patients with dilated cardiomyopathy versus healthy subjects. Ann Noninvasive Electrocardiol. 2005 Apr; 10(2):121-8.
-
Zareba W, Bayes de Luna A. QT dynamics and variability. Ann Noninvasive Electrocardiol. 2005 Apr; 10(2):256-62.
-
Yoerger DM, Marcus F, Sherrill D, Calkins H, Towbin JA, Zareba W, Picard MH. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol. 2005 Mar 15; 45(6):860-5.
-
Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, Huang LS, Cox C, Zareba W, Oberdörster G. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med. 2005 May 15; 171(10):1129-35.
-
Narins CR, Dozier AM, Ling FS, Zareba W. The influence of public reporting of outcome data on medical decision making by physicians. Arch Intern Med. 2005 Jan 10; 165(1):83-7.
-
Couderc JP, Xiaojuan X, Zareba W, Moss AJ. Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol. 2005 Jan; 10(1):25-34.
-
Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004 Dec 21; 110(25):3760-5.
-
Corsetti JP, Zareba W, Moss AJ, Sparks CE. Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome. Atherosclerosis. 2004 Dec; 177(2):367-73.
-
Frampton MW, Utell MJ, Zareba W, Oberdörster G, Cox C, Huang LS, Morrow PE, Lee FE, Chalupa D, Frasier LM, Speers DM, Stewart J. Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma. Res Rep Health Eff Inst. 2004 Dec; (126):1-47; discussion 49-63.
-
Zareba W. Implantable cardioverter defibrillator therapy in postinfarction patients. Curr Opin Cardiol. 2004 Nov; 19(6):619-24.
-
Zareba W. Idiopathic VF and short repolarization: intriguing new concept. Heart Rhythm. 2004 Nov; 1(5):592-3.
-
Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2004 Oct 6; 44(7):1481-7.
-
Cygankiewicz I, Wranicz JK, Bolinska H, Zaslonka J, Zareba W. Circadian changes in heart rate turbulence parameters. J Electrocardiol. 2004 Oct; 37(4):297-303.
-
Fiol M, Carrillo A, Cygankiewicz I, Ayestarán J, Caldés O, Peral V, Bethencourt A, Zareba W, de Luna AB. New criteria based on ST changes in 12-lead surface ECG to detect proximal versus distal right coronary artery occlusion in a case of acute inferoposterior myocardial infarction. Ann Noninvasive Electrocardiol. 2004 Oct; 9(4):383-8.
-
Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, McNitt SA, Andrews ML. Temporal aspects of improved survival with the implanted defibrillator (MADIT-II). Am J Cardiol. 2004 Aug 1; 94(3):312-5.
-
Cygankiewicz I, Wranicz JK, Bolinska H, Zaslonka J, Jaszewski R, Zareba W. Influence of coronary artery bypass grafting on heart rate turbulence parameters. Am J Cardiol. 2004 Jul 15; 94(2):186-9.
-
Cygankiewicz I, Wranicz JK, Bolinska H, Zaslonka J, Zareba W. Relationship between heart rate turbulence and heart rate, heart rate variability, and number of ventricular premature beats in coronary patients. J Cardiovasc Electrophysiol. 2004 Jul; 15(7):731-7.
-
Berkowitsch A, Zareba W, Neumann T, Erdogan A, Nitt SM, Moss AJ, Pitschner HF. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording. Ann Noninvasive Electrocardiol. 2004 Jul; 9(3):270-9.
-
Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost. 2004 May; 2(5):718-25.
-
Fiol M, Cygankiewicz I, Guindo J, Flotats A, Genis AB, Carreras F, Zareba W, de Luna AB. Evolving myocardial infarction with ST elevation: ups and downs of ST in different leads identifies the culprit artery and location of the occlusion. Ann Noninvasive Electrocardiol. 2004 Apr; 9(2):180-6.
-
Wranicz JK, Rosiak M, Cygankiewicz I, Kula P, Kula K, Zareba W. Sex steroids and heart rate variability in patients after myocardial infarction. Ann Noninvasive Electrocardiol. 2004 Apr; 9(2):156-61.
-
Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004 Apr 20; 109(15):1826-33.
-
Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004 Mar 9; 109(9):1082-4.
-
Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, Lichstein E. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004 Feb 23; 164(4):440-6.
-
Sarapa N, Morganroth J, Couderc JP, Francom SF, Darpo B, Fleishaker JC, McEnroe JD, Chen WT, Zareba W, Moss AJ. Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol. 2004 Jan; 9(1):48-57.
-
Karcz M, Chojnowska L, Zareba W, Ruzyllo W. [In dilated cardiomyopathy normal signal-averaged electrocardiogram does not identify low mortality risk patients]. Pol Merkur Lekarski. 2003 Dec; 15(90):537-9.
-
Corsetti JP, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rainwater DL, Sparks CE. Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients. Atherosclerosis. 2003 Dec; 171(2):351-8.
-
Zareba W, Moss AJ, Sheu G, Kaufman ES, Priori S, Vincent GM, Towbin JA, Benhorin J, Schwartz PJ, Napolitano C, Hall WJ, Keating MT, Qi M, Robinson JL, Andrews ML. Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1149-53.
-
Perkiomaki JS, Couderc JP, Daubert JP, Zareba W. Temporal complexity of repolarization and mortality in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2003 Oct; 26(10):1931-6.
-
Cygankiewicz I, Wranicz JK, Zaslonka J, Bolinska H, Zareba W. Clinical covariates of abnormal heart rate turbulence in coronary patients. Ann Noninvasive Electrocardiol. 2003 Oct; 8(4):289-95.
-
Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol. 2003 Jul 2; 42(1):103-9.
-
Ning L, Moss AJ, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome). Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):246-50.
-
Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, Gear K. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation. 2003 Jun 17; 107(23):2975-8.
-
Cygankiewicz I, Wranicz JK, Bolinska H, Zaslonka J, Jaszewski R, Zareba W. Prognostic significance of heart rate turbulence in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2003 Jun 15; 91(12):1471-4, A8.
-
Harb TS, Zareba W, Moss AJ, Ridker PM, Rifai N, Marder VJ, Miller-Watelet L. Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. Am J Cardiol. 2003 May 1; 91(9):1120-3.
-
Sesselberg HW, Moss AJ, Steinberg J, Carroll E, Zareba W, Daubert J, Huang DT. Factors associated with ventricular inducibility in the MADIT-II study population. Am J Cardiol. 2003 Apr 15; 91(8):1002-4, A7.
-
Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003 Apr; 14(4):337-41.
-
Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, Carroll ER. History of hypertension and enhanced thrombogenic activity in postinfarction patients. Hypertension. 2003 Apr; 41(4):943-9.
-
Zareba W. QT-RR slope: dynamics of repolarization in the risk stratification. J Cardiovasc Electrophysiol. 2003 Mar; 14(3):234-5.
-
Karcz M, Chojnowska L, Zareba W, Ruzyllo W. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol. 2003 Jan; 87(1):75-81.
-
Couderc JP, Zareba W, Moss AJ, Sarapa N, Morganroth J, Darpo B. Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters. J Electrocardiol. 2003; 36 Suppl:115-20.
-
Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr Q. 2003; 74(3):291-306.
-
Ning L, Moss A, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test. 2003; 7(3):249-53.
-
Zareba W, Moss AJ. Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy. J Electrocardiol. 2003; 36 Suppl:101-8.
-
Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol. 2002 Dec; 14(12):1231-47.
-
Moss AJ, Daubert J, Zareba W. MADIT-II: clinical implications. Card Electrophysiol Rev. 2002 Dec; 6(4):463-5.
-
Perkiomaki JS, Zareba W, Badilini F, Moss AJ. Influence of atropine on fractal and complexity measures of heart rate variability. Ann Noninvasive Electrocardiol. 2002 Oct; 7(4):326-31.
-
Perkiomaki JS, Zareba W, Greenberg HM, Moss AJ. Usefulness of standard electrocardiographic parameters for predicting cardiac events after acute myocardial infarction during modern treatment era. Am J Cardiol. 2002 Aug 1; 90(3):205-9.
-
Perkiömäki JS, Zareba W, Nomura A, Andrews M, Kaufman ES, Moss AJ. Repolarization dynamics in patients with long QT syndrome. J Cardiovasc Electrophysiol. 2002 Jul; 13(7):651-6.
-
Wang Z, Li H, Moss AJ, Robinson J, Zareba W, Knilans T, Bowles NE, Towbin JA. Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsen syndrome. Mol Genet Metab. 2002 Apr; 75(4):308-16.
-
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21; 346(12):877-83.
-
Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation. 2002 Feb 19; 105(7):794-9.
-
Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, Krone RJ, Liang CS, Lichstein E, Little W, Marcus FI, Oakes D, Sparks CE, VanVoorhees L. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol. 2002 Jan 15; 89(2):216-21.
-
Benhorin J, Moss AJ, Bak M, Zareba W, Kaufman ES, Kerem B, Towbin JA, Priori S, Kass RS, Attali B, Brown AM, Ficker E. Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations. Ann Noninvasive Electrocardiol. 2002 Jan; 7(1):40-6.
-
Zareba W. New era for digital ECG: FDA requires digital ECG submission for tested drugs. Ann Noninvasive Electrocardiol. 2002 Jan; 7(1):1-3.
-
Hajj-Ali R, Zareba W, Ezzeddine R, Moss AJ. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001 Dec 1; 88(11):1221-4.
-
Zareba W, Sattari MN, Rosero S, Couderc JP, Moss AJ. Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation. Am J Cardiol. 2001 Dec 1; 88(11):1311-4.
-
Perkiömäki JS, Zareba W, Ruta J, Dubner S, Madoery C, Deedwania P, Karcz M, Bayes de Luna A. Fractal and complexity measures of heart rate dynamics after acute myocardial infarction. Am J Cardiol. 2001 Oct 1; 88(7):777-81.
-
Moss AJ, Zareba W, Benhorin J, Couderc JP, Kennedy H, Locati-Heilbron E, Maison-Blanche P. ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization. Ann Noninvasive Electrocardiol. 2001 Oct; 6(4):333-41.
-
Perkiömäki JS, Zareba W, Couderc JP, Moss AJ. Heart rate variability in patients with congenital long QT syndrome. Ann Noninvasive Electrocardiol. 2001 Oct; 6(4):298-304.
-
Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators. Thromb Haemost. 2001 Sep; 86(3):791-9.
-
Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol. 2001 Sep 1; 88(5):516-20.
-
Zareba W, Nomura A, Couderc JP. Cardiovascular effects of air pollution: what to measure in ECG? Environ Health Perspect. 2001 Aug; 109 Suppl 4:533-8.
-
Kimbrough J, Moss AJ, Zareba W, Robinson JL, Hall WJ, Benhorin J, Locati EH, Medina A, Napolitano C, Priori S, Schwartz PJ, Timothy K, Towbin JA, Vincent GM, Zhang L. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001 Jul 31; 104(5):557-62.
-
Perkiömäki JS, Zareba W, Daubert JP, Couderc JP, Corsello A, Kremer K. Fractal correlation properties of heart rate dynamics and adverse events in patients with implantable cardioverter-defibrillators. Am J Cardiol. 2001 Jul 1; 88(1):17-22.
-
Vulapalli R, Liang C, Zareba W, Moss AJ. Recurrent coronary events are not increased in postinfarction patients with methylenetetrahydrofolate reductase gene C677T polymorphism. Am J Cardiol. 2001 Jun 1; 87(11):1289-92.
-
Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL, Jouven X, Kuller LH, MacCluer JW, Marbán E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II. Circulation. 2001 May 22; 103(20):2447-52.
-
Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL, Jouven X, Kuller LH, MacCluer JW, Marbán E, Muller JE, Schwartz PJ, Siscovick DS, Tracy RP, Zareba W, Zipes DP. Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation. 2001 May 15; 103(19):2361-4.
-
Perkiömäki JS, Zareba W, Kalaria VG, Couderc J, Huikuri HV, Moss AJ. Comparability of nonlinear measures of heart rate variability between long- and short-term electrocardiographic recordings. Am J Cardiol. 2001 Apr 1; 87(7):905-8.
-
Windle JR, Geletka RC, Moss AJ, Zareba W, Atkins DL. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol. 2001 Apr; 6(2):153-8.
-
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001 Jan 2; 103(1):89-95.
-
Zareba W, Moss AJ. Long QT syndrome in children. J Electrocardiol. 2001; 34 Suppl:167-71.
-
Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000 Dec 5; 102(23):2849-55.
-
Watelet LF, Moss AJ, Zareba W, Oakes D, Ryan D. Detection of a group of risk factors in coronary disease using a new carriership analysis approach. Am J Cardiol. 2000 Dec 1; 86(11):1253-6, A6.
-
Fisher SD, Zareba W, Moss AJ, Marder VJ, Sparks CE, Hochman J, Liang C, Krone RJ. Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction. Am J Cardiol. 2000 Oct 15; 86(8):813-8.
-
Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation. 2000 Sep 12; 102(11):1258-63.
-
Goldman DS, Zareba W, Moss AJ. Malignant T-wave alternans. Circulation. 2000 Aug 22; 102(8):E46-7.
-
Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF. Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol. 2000 Jun 15; 85(12):1401-8.
-
Ali RH, Zareba W, Moss AJ, Schwartz PJ, Benhorin J, Vincent GM, Locati EH, Priori S, Napolitano C, Towbin JA, Hall WJ, Robinson JL, Andrews ML, Zhang L, Timothy K, Medina A. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol. 2000 Feb 15; 85(4):457-61.
-
Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000 Feb 15; 101(6):616-23.
-
Nomura A, Zareba W, Moss AJ. Obesity does not influence electrocardiographic parameters in coronary patients. Am J Cardiol. 2000 Jan 1; 85(1):106-8, A9.
-
Rosero SZ, Zareba W, Moss AJ, Robinson JL, Hajj Ali RH, Locati EH, Benhorin J, Andrews ML. Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group. Am J Cardiol. 1999 Dec 15; 84(12):1406-11.
-
Marder VJ, Zareba W, Horan JT, Moss AJ, Kanouse JJ. Automated latex agglutination and ELISA testing yield equivalent D-dimer results in patients with recent myocardial infarction. THROMBO Research Investigators. Thromb Haemost. 1999 Nov; 82(5):1412-6.
-
Couderc JP, Zareba W, Burattini L, Moss AJ. Beat-to-Beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation. Pacing Clin Electrophysiol. 1999 Nov; 22(11):1581-92.
-
Moss AJ, Robinson JL, Gessman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999 Oct 15; 84(8):876-9.
-
Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM, Arora R, Marcus FI, Watelet LF, Case RB. Thrombogenic factors and recurrent coronary events. Circulation. 1999 May 18; 99(19):2517-22.
-
Burattini L, Zareba W. Time-domain analysis of beat-to-beat variability of repolarization morphology in patients with ischemic cardiomyopathy. J Electrocardiol. 1999; 32 Suppl:166-72.
-
Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998 Oct 1; 339(14):960-5.
-
Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998 Jun 9; 97(22):2237-44.
-
Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ, Andrews M. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation. 1998 Feb 10; 97(5):451-6.
-
Burattini L, Zareba W, Rashba EJ, Couderc JP, Konecki J, Moss AJ. ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J Electrocardiol. 1998; 31 Suppl:114-20.
-
Zareba W, Moss AJ, Konecki J. TU wave area-derived measures of repolarization dispersion in the long QT syndrome. J Electrocardiol. 1998; 30 Suppl:191-5.
-
Couderc JP, Zareba W, Burattini L, Konecki JA, Moss AJ. Beat-to-beat repolarization variability in amplitude and duration in LQTS patients with the SCN5A sodium channel gene mutation. J Electrocardiol. 1998; 31 Suppl:134.
-
Zareba W, Moss AJ, Rosero SZ, Hajj-Ali R, Konecki J, Andrews M. Electrocardiographic findings in patients with diphenhydramine overdose. Am J Cardiol. 1997 Nov 1; 80(9):1168-73.
-
Emond MJ, Zareba W. Prognostic value of cholesterol in women of different ages. J Womens Health. 1997 Jun; 6(3):295-307.
-
Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol. 1997 Mar 15; 29(4):756-63.
-
Zareba W. [Ambulatory ekg monitoring--development and clinical use of Holter's method]. Pol Tyg Lek. 1996 Mar; 51(10-13):127-30.
-
Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, Andrews ML. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 1995 Dec; 26(7):1685-91.
-
Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995 Nov 15; 92(10):2929-34.
-
Martin AB, Perry JC, Robinson JL, Zareba W, Moss AJ, Garson A. Calculation of QTc duration and variability in the presence of sinus arrhythmia. Am J Cardiol. 1995 May 1; 75(14):950-2.
-
Zareba W, Moss AJ. Dispersion of repolarization. Relation to heart rate and repolarization duration. J Electrocardiol. 1995; 28 Suppl:202-6.
-
Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. The Multicenter Myocardial Ischemia Research Group. Coron Artery Dis. 1994 Dec; 5(12):1009-18.
-
Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. Coron Artery Dis. 1994 Oct; 5(10):857-64.
-
Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994 Sep 15; 74(6):550-3.
-
Moss AJ, Zareba W. Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs. Coron Artery Dis. 1994 Aug; 5(8):665-70.
-
Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994 Jun; 23(7):1541-6.
-
Zareba W, Badilini F, Moss AJ. Automatic detection of spatial and dynamic heterogeneity of repolarization. J Electrocardiol. 1994; 27 Suppl:66-72.
-
Zareba W. [Norman J. Holter--"father" of ambulatory ECG monitoring]. Kardiol Pol. 1991; 35(12):368-70.
-
Zareba W, Pracka H, Oszczygiel S, Dabrowski A, Giec L, Trusz-Gluza M, Marciniak W, Ciemniewski Z, Piwonski M. [Late ventricular potentials and ventricular arrhythmia in patients with stable ischemic heart disease]. Kardiol Pol. 1990; 33(7):16-22.
-
Bolinska H, Chizynski K, Zareba W, Iwaszkiewicz-Zaslonka A. [Therapeutic problems in torsade de pointes ventricular tachycardia]. Pol Tyg Lek. 1986 Oct 13; 41(41):1306-8.
|
Zareba's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
